In 2019 CHEM PAP published article about ANTIBACTERIAL ACTIVITY; BIOLOGICAL EVALUATION; LEAF-BLIGHT; ANALOGS; DESIGN; POTENT; WILT; GENOME in [Tian, Kun; Li, Xiao-Qin; Zhang, Li; Wu, Shou-Qun; Wan, Jin-Lin; Ouyang, Gui-Ping] Guizhou Univ, State Key Lab Breeding Base Green Pesticide & Agr, Key Lab Green Pesticide & Agr Bioengn, Minist Educ,Ctr Res & Dev Fine Chem, Guiyang 550025, Guizhou, Peoples R China; [Gan, Yi-Yuan; Meng, Jiao; Xu, Yang; Cai, Chao-Ting; Ouyang, Gui-Ping; Wang, Zhen-Chao] Guizhou Univ, Coll Pharm, Guiyang 550025, Guizhou, Peoples R China; [Ouyang, Gui-Ping; Wang, Zhen-Chao] Drug Synthet Engn Lab Guizhou Prov, Guiyang 550025, Guizhou, Peoples R China in 2019, Cited 37. The Name is 2,4-Dichlorobenzoic acid. Through research, I have a further understanding and discovery of 50-84-0. Quality Control of 2,4-Dichlorobenzoic acid
A series of novel indole derivatives containing double 1,3,4-oxadiazole moiety was designed, synthesized and evaluated for their antibacterial activities in vitro. These compounds were fully characterized by H-1 NMR, C-13 NMR, and HRMS. Bioassay results indicated that most of title compounds exhibited excellent antibacterial activities against rice bacterial pathogen Xanthomonas oryzae (Xoo). For example, compounds 7d, 7h, 7i, 7j, 7k, 7l and 7m had the half-maximal effective concentration (EC50) values of 52.31, 54.12, 40.65, 38.80, 51.13, 52.75 and 50.66 mu g/mL, respectively, which was better than that of commercial product bismerthiazol (BMT) (85.18 mu g/mL). The experimental results proved that indole derivatives bearing double 1,3,4-oxadiazole unit are promising candidates for the development of new agricultural bactericides against pathogenic bacterium Xoo. [GRAPHICS] .
Welcome to talk about 50-84-0, If you have any questions, you can contact Tian, K; Li, XQ; Zhang, L; Gan, YY; Meng, J; Wu, SQ; Wan, JL; Xu, Y; Cai, CT; Ouyang, GP; Wang, ZC or send Email.. Quality Control of 2,4-Dichlorobenzoic acid
Reference:
Chloride – Wikipedia,
,Chlorides – an overview | ScienceDirect Topics